Genotype and haplotype determination of IL1B (g. - 511C > T and g. + 3954C > T) and (IL1RN) in pediatric nephrolithiasis

Clinica Chimica Acta

Volumn 379, Issue 1-2, 2007, Pages 42-47

  Mittal, Rama D ^a   Bid, Hemant K ^a   Manchanda, Parmeet K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

IL 1Ra gene; IL1B; PCR RFLP; Pediatric nephrolithiasis; SNP

Indexed keywords

ADOLESCENT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE; GENE IDENTIFICATION; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; INTERLEUKIN 1 RECEPTOR ANGONIST GENE; INTERLEUKIN 1B GENE; NEPHROLITHIASIS; PEDIATRICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; TANDEM REPEAT;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; MALE; NEPHROLITHIASIS; POLYMORPHISM, GENETIC;

EID: 33847645790     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.12.004     Document Type: Article

References (26)

1. Edvardsson V., Elidottir H., Indridason O.S., and Palsson R. High incidence of kidney stones in Icelandic children. Pediatr Nephrol 20 (2005) 940-944
2. Leumann E., and Hoppe B. Urolithiasis in childhood. In: Proesmans W. (Ed). Therapeutic strategies in children with renal disease. Baillieres Clin Paediatr vol. 5 (1997) 655-674
3. Yoshida O., Terai A., Ohkawa T., and Okada Y. National trend of the incidence of urolithiasis in Japan from 1965-1995. Kidney Int 56 (1999) 1899-1904
4. Walter P.C., Lamm D., and Kaplan G.W. Childhood urolithiasis: a ten-year review. Pediatrics 65 (1980) 1068-1078
5. Weisinger J.R., Alonzo E., Bellorin-Font E., et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49 (1996) 244-250
6. Yang J., Hu Z., Xu Y., et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 215 (2004) 191-198
7. Chen W.C., Wu H.C., Chen H.Y., Wu M.C., Hsu C.D., and Tsai F.J. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 29 (2001) 314-321
8. Guasch J.F., Bertina R.M., and Reitsma P.H. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 8 (1996) 598-602
9. Blakemore A.I., Tarlow J.K., Cork M.J., Gordon C., Emery P., and Duff G.W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37 (1994) 1380-1385
10. Chen W.C., Wu H.C., Chen H.Y., Wu M.C., Hsu C.D., and Tsai F.J. Interleukin-1β gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 29 (2001) 321-324
11. Cameron M.A., Sakhaee K., and Moe O.W. Nephrolithiasis in children. Pediatr Nephrol 20 (2005) 1587-1592
12. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3 (1976) 2303-2308
13. Bioque G., Crusius J.B.A., Koutroubakis I., et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-Ra) genes in inflammatory bowl disease. Clin Exp Immunol 102 (1995) 379-383
14. Bid H.K., Chaudhary H., and Mittal R.D. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr Nephrol 20 (2005) 773-776
15. Nakamura E., Takahashi S., Ishikawa M., and Okabe S. Inhibitory effect of macrophage-derived factors on the recovery of wounds induced in rat gastric epithelial monolayers. Biochem Pharmacol 58 (1999) 1221-1227
16. Lennard A.C. Interleukin-1 receptor antagonist. Crit Rev Immunol 15 (1995) 77-105
17. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 28 (1998) 2598-2602
18. Joos L., McIntyre L., Ruan J., et al. Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 56 (2001) 863-866
19. Arned W. Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J Clin Invest 5 (1991) 1445-1451
20. Weale M.E., Depondt C., Macdonald S.J., et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet 73 (2003) 551-565
21. Stapleton F.B. Childhood stones. Endocrinol Metab Clin North Am 31 (2002) 1001-1005
22. Pak C.Y. Kidney stones. Lancet 351 (1998) 1797-1801
23. Goodman H.O., Brommage R., Assimos D.G., and Holmes R.P. Genes in idiopathic calcium oxalate stone disease. World J Urol 15 (1997) 186-194
24. Capasso G., Jaeger P., Robertson W.G., and Unwin R.J. Uric acid and the kidney: urate transport, stone disease and progressive renal failure. Curr Pharm Des 11 (2005) 4153-4159
25. Jungers P., Joly D., Barbey F., Choukroun G., and Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44 (2004) 799-805
26. Cameron M.A., Sakhaee K., and Moe O.W. Nephrolithiasis in children. Pediatr Nephrol 20 (2005) 1587-1592